Association between PAI-1 4G/5G Polymorphisms and osteonecrosis of femoral head: A Meta-analysis

Thrombosis Research

Volumn 132, Issue 2, 2013, Pages 158-163

  Liang, Xiao Nan ^a   Xie, Li ^a   Cheng, Jian Wen ^a   Tan, Zhen ^a   Yao, Jun ^a   Liu, Qian ^a   Su, Wei ^a   Qin, Xue ^a   Zhao, Jin Min ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

activator inhibitor 1; Meta analysis; Osteonecrosis; Plasminogen; Polymorphism

Indexed keywords

DNA POLYMORPHISM; FEMUR HEAD NECROSIS; GENE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; META ANALYSIS; PLASMINOGEN ACTIVATOR INHIBITOR 1 GENE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

META-ANALYSIS; OSTEONECROSIS; PLASMINOGEN ACTIVATOR INHIBITOR-1; POLYMORPHISM;

CASE-CONTROL STUDIES; FEMUR HEAD NECROSIS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; OSTEONECROSIS; PLASMINOGEN ACTIVATOR INHIBITOR 1; RISK FACTORS;

EID: 84883754752     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.06.023     Document Type: Review

References (31)

1. C.G. Zalavras, G. Vartholomatos, E. Dokou, and K.N. Malizos Genetic background of osteonecrosis: associated with thrombophilic mutations? Clin Orthop Relat Res 2004 251 255
2. A. Bjorkman, I.M. Burtscher, P.J. Svensson, A. Hillarp, and J. Besjakov Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the knee Arch Orthop Trauma Surg 125 2005 51 55
3. A. Bjorkman, P.J. Svensson, A. Hillarp, I.M. Burtscher, and A. Runow Factor V leiden and prothrombin gene mutation: risk factors for osteonecrosis of the femoral head in adults Clin Orthop Relat Res 2004 168 172
4. A. Celik, D. Tekis, F. Saglam, S. Tunali, and N. Kabakci Association of corticosteroids and factor V, prothrombin, and MTHFR gene mutations with avascular osteonecrosis in renal allograft recipients Transplant Proc 38 2006 512 516
5. J.D. Chang, M. Hur, S.S. Lee, J.H. Yoo, and K.M. Lee Genetic background of nontraumatic osteonecrosis of the femoral head in the Korean population Clin Orthop Relat Res 466 2008 1041 1046
6. X.F. Shang, H. Su, W.W. Chang, C.C. Wang, and Q. Han Association between MTHFR C677T polymorphism and osteonecrosis of the femoral head: a meta-analysis Mol Biol Rep 39 2012 7089 7094
7. P. Eriksson, B. Kallin, F.M. van 't Hooft, P. Bavenholm, and A. Hamsten Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction Proc Natl Acad Sci U S A 92 1995 1851 1855
8. P. Ferrari, V. Schroeder, S. Anderson, L. Kocovic, and B. Vogt Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients Transplantation 74 2002 1147 1152
9. C.J. Glueck, R.N. Fontaine, R. Gruppo, D. Stroop, and L. Sieve-Smith The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis Clin Orthop Relat Res 1999 133 146
10. W. Sun, Z. Li, Z. Shi, B. Wang, and X. Cong Relationship between Post-SARS osteonecrosis and PAI-1 4 G/5 G gene polymorphisms Orthop J China 16 2008
11. H. Kim, C. Cho, Y. Cho, S. Cho, and K. Yoon Significant associations of PAI-1 genetic polymorphisms with osteonecrosis of the femoral head BMC Musculoskelet Disord 12 2011 160
12. C.J. Glueck, R.A. Freiberg, R.N. Fontaine, T. Tracy, and P. Wang Hypofibrinolysis, thrombophilia, osteonecrosis Clin Orthop Relat Res 2001 19 33
13. T. Asano, K.A. Takahashi, M. Fujioka, S. Inoue, and K. Ueshima Relationship between postrenal transplant osteonecrosis of the femoral head and gene polymorphisms related to the coagulation and fibrinolytic systems in Japanese subjects Transplantation 77 2004 220 225
14. J. Bond, S. Adams, S. Richards, A. Vora, and C. Mitchell Polymorphism in the PAI-1 (SERPINE1) gene and the risk of osteonecrosis in children with acute lymphoblastic leukemia Blood 118 2011 2632 2633
15. D. French, L.H. Hamilton, L.A. Mattano Jr., H.N. Sather, and M. Devidas A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group Blood 111 2008 4496 4499
16. M.A. Mont, and D.S. Hungerford Non-traumatic avascular necrosis of the femoral head J Bone Joint Surg Am 77 1995 459 474
17. C.J. Glueck, R. Freiberg, T. Tracy, D. Stroop, and P. Wang Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis Clin Orthop Relat Res 1997 43 56
18. C. Zalavras, Z. Dailiana, M. Elisaf, E. Bairaktari, and P. Vlachogiannopoulos Potential aetiological factors concerning the development of osteonecrosis of the femoral head Eur J Clin Invest 30 2000 215 221
19. A.E. Tsantes, G.K. Nikolopoulos, P.G. Bagos, E. Rapti, and G. Mantzios Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis. A meta-analysis Thromb Haemost 97 2007 907 913
20. M.C. Alessi, M. Poggi, and I. Juhan-Vague Plasminogen activator inhibitor-1, adipose tissue and insulin resistance Curr Opin Lipidol 18 2007 240 245
21. C. Lara-Castro, Y. Fu, B.H. Chung, and W.T. Garvey Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease Curr Opin Lipidol 18 2007 263 270
22. K. Miyanishi, Y. Kamo, H. Ihara, T. Naka, and M. Hirakawa Risk factors for dysbaric osteonecrosis Rheumatology 45 2006 855 858
23. X. Tan, D. Cai, Y. Wu, B. Liu, and L. Rong Comparative analysis of serum proteomes: discovery of proteins associated with osteonecrosis of the femoral head Transl Res 148 2006 114 119
24. S. Dawson, A. Hamsten, B. Wiman, A. Henney, and S. Humphries Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity Arterioscler Thromb 11 1991 183 190
25. L. Iacoviello, F. Burzotta, A. Di Castelnuovo, F. Zito, and R. Marchioli The 4G/5G polymorphism of PAI-1 promoter gene and the risk of myocardial infarction: a meta-analysis Thromb Haemost 80 1998 1029 1030
26. Y.Y. Li Plasminogen activator inhibitor-1 4G/5G gene polymorphism and coronary artery disease in the Chinese Han population: a meta-analysis PLoS One 7 2012 e33511
27. W. Nie, B. Li, and Q.Y. Xiu The -675 4G/5G polymorphism in plasminogen activator inhibitor-1 gene is associated with risk of asthma: a meta-analysis PLoS One 7 2012 e34385
28. C.J. Glueck, R.A. Freiberg, L. Sieve, and P. Wang Enoxaparin prevents progression of stages I and II osteonecrosis of the hip Clin Orthop Relat Res 2005 164 170
29. E. Peled, M. Davis, E. Axelman, D. Norman, and Y. Nadir Heparanase role in the treatment of avascular necrosis of femur head Thromb Res 131 2013 94 98
30. N. Rosenberg, M. Murata, Y. Ikeda, O. Opare-Sem, and A. Zivelin The frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in whites, Japanese, and Africans Am J Hum Genet 70 2002 758 762
31. A.H. Sadewa, Sutomo R. Sunarti, C. Hayashi, and M.J. Lee The C677T mutation in the methylenetetrahydrofolate reductase gene among the Indonesian Javanese population Kobe J Med Sci 48 2002 137 144